M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY

Detalles Bibliográficos
Autores principales: Szafron, V., Pereira, M., Vogel, T., Leung, D., Forbes-Satter, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661922/
http://dx.doi.org/10.1016/j.anai.2020.08.359
_version_ 1783609298423644160
author Szafron, V.
Pereira, M.
Vogel, T.
Leung, D.
Forbes-Satter, L.
author_facet Szafron, V.
Pereira, M.
Vogel, T.
Leung, D.
Forbes-Satter, L.
author_sort Szafron, V.
collection PubMed
description
format Online
Article
Text
id pubmed-7661922
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-76619222020-11-13 M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY Szafron, V. Pereira, M. Vogel, T. Leung, D. Forbes-Satter, L. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2020-11 2020-11-13 /pmc/articles/PMC7661922/ http://dx.doi.org/10.1016/j.anai.2020.08.359 Text en Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Szafron, V.
Pereira, M.
Vogel, T.
Leung, D.
Forbes-Satter, L.
M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title_full M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title_fullStr M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title_full_unstemmed M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title_short M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY
title_sort m412 a balancing act: treatment of covid-19 and cytomegalovirus in a patient with primary immunodeficiency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661922/
http://dx.doi.org/10.1016/j.anai.2020.08.359
work_keys_str_mv AT szafronv m412abalancingacttreatmentofcovid19andcytomegalovirusinapatientwithprimaryimmunodeficiency
AT pereiram m412abalancingacttreatmentofcovid19andcytomegalovirusinapatientwithprimaryimmunodeficiency
AT vogelt m412abalancingacttreatmentofcovid19andcytomegalovirusinapatientwithprimaryimmunodeficiency
AT leungd m412abalancingacttreatmentofcovid19andcytomegalovirusinapatientwithprimaryimmunodeficiency
AT forbessatterl m412abalancingacttreatmentofcovid19andcytomegalovirusinapatientwithprimaryimmunodeficiency

Ejemplares similares